Navigation Links
Novus International to Present Scientific Findings on Prebiotics during Aquaculture Europe 2013
Date:8/6/2013

ST. LOUIS, Aug. 6, 2013 /PRNewswire/ -- Aquaculture Europe 2013 will take place in Trondheim, Norway on August 9th and Novus will be present to support this important international industry conference. The theme of this year's event, Making Sense of Science, implies setting priorities for knowledge generation.

(Logo: http://photos.prnewswire.com/prnh/20130806/CG59070LOGO)

"Novus is firmly committed to supporting the aquaculture industry, which continues to experience tremendous growth," notes Dr. Francisco Gomes, Executive Manager, Novus Aqua. "Novus embraces every opportunity it has to share the scientific research and information that is the foundation for the development of products and solutions that maximize efficiency and profitability at every stage in the aquaculture production chain."

Knowledge sharing is a key aspect of the organizational culture at Novus. "We're continually focusing on the needs of the animal and the understanding of our customer's value chain," noted Dr. Gomes. "We have invested extensive resources in the European marine fish industry. Through strategic partnerships with customers and research partners we have been able to achieve significant milestones in issues such as sea lice myxosporidia and enteritis."

Craig Browdy, Novus Executive Manager, Aquaculture Research, will be presenting a scientific abstract on Saturday, August 10th beginning at 10:50 a.m. Entitled, Mode of action and practical applications of the prebiotic PREVIDA® to improve fish health, the abstract will discuss the results of a series of in vitro, in vivo and ex vivo field and lab tests with PREVIDA®. In this research PREVIDA binded with bacterial binding receptors, which left them inaccessible to pathogens, encouraged selective fermentation allowing beneficial bacteria to completely exclude pathogens, and caused significant improvements in gut ultrastructure. These benefits resulted in a reduction of enteritis and improvement in performance in sensitive marine species.

PREVIDA® is a single-source material which has a consistent composition and is of 100 percent natural origin with no added chemicals. Introduced by Novus in 2011, this breakthrough prebiotic won the 2012 North American New Product Innovation Award for Prebiotics. PREVIDA is part of Novus Aqua Health Through Nutrition Solutions.  Our complete portfolio of gut environment modifiers together with our expertise have positioned our technologies as successful tools across the world and the industry.

To learn more about the comprehensive programs and products Novus has available to support the production efficiency and profitability of the aquaculture industry, visit the company's corporate web site at www.novusint.com.

About Novus International, Inc.

Novus International, Inc. is headquartered in metropolitan St. Louis, Missouri, U.S.A. and serves customers in nearly 100 countries around the world. A global leader in developing animal health and nutrition solutions, Novus's products include ALIMET® and MHA® feed supplements, ACTIVATE® nutritional feed acid, ACIDOMIX® preservative premixture, ADVENT® coccidiosis control, CIBENZA® feed additive, MINTREX® chelated trace mineral, SANTOQUIN® feed preservative, MERA™MET aquaculture feed additive, AGRADO® feed antioxidant and many other specialty ingredients. Stratum® Nutrition, a division of Novus Nutrition Brands, LLC, focuses on human nutrition through specialty and functional ingredients for manufacturers of foods, beverages and dietary supplements (www.stratumnutrition.com). Novus is privately owned by Mitsui & Co. (U.S.A.), Inc. and Nippon Soda Co., Ltd. For more information visit www.novusint.com.

®NOVUS, ALIMET, MHA, ACTIVATE, ACIDOMIX, CIBENZA, MAAC, MINTREX, SANTOQUIN and AGRADO are trademarks of Novus International, Inc. and are registered in the United States and other countries. ®ADVENT is a trademark of Viridus Animal Health, LLC, and is registered in the United States and other countries. ®STRATUM NUTRITION is a trademark of Novus Nutrition Brands, LLC, and is registered in the United States and other countries. ®PREVIDA is a registered trademark of TIN, Inc.  ™MERA and SOLUTIONS SERVICE SUSTAINABILITY are trademarks of Novus International, Inc. © 2013 Novus International, Inc. All rights reserved.

CONTACTS: Tracy Barfield
636.794.2411
tracy.barfield@novusint.com

Barbara Hansen
636.926.7436
barbara.hansen@novusint.com


'/>"/>
SOURCE Novus International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Novus International And Verenium Announce Important Progress In The Development Of Novel Enzymes For Animal Health & Nutrition
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
5. GeneCell International, Miami’s Preferred Cord Blood Laboratory, is Pleased to Announce That July is National Cord Blood Awareness Month
6. Join Cornerstone Plastic Surgery for an Exclusive Evening with Internationally Reknowned New York Trained Plastic Surgeon Frederick A. Coville, MD
7. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
8. Cellular Dynamics International Announces Launch of Initial Public Offering
9. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
10. Rocky Mountain Biologicals Joins International Serum Industry Association
11. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):